FTO and metabolic dysfunction-associated steatotic liver disease: Currently, no experimental data of exenatide on fatty liver patients are available.Therefore, we investigated whether the protective role of exenatide on NAFLD ismediated via FTO gene expression and through modulation of PI3Ksignaling pathway in high-fat (HF) diet-induced obese New Zealand rabbits andrelated cell culture models.